title: Acyclovir-resistant herpetic keratitis in a solid-organ transplant recipient on systemic immunosuppression.
abstract: OBJECTIVE
  To report a case of acyclovir-resistant herpetic keratitis in a solid-organ lung transplant recipient that was effectively treated with topical trifluridine.
  
  
  METHODS
  A case of a 35-year-old female with herpetic epithelial keratitis resistant to acyclovir is described. The patient presented following treatment for 4 weeks with topical acyclovir ointment five times per day and oral valacyclovir 1 g three times per day for herpetic keratitis with no resolution of the epithelial defect or symptoms. Corneal scrapes and swabs were taken for confirmation of the diagnosis and resistance testing. The results were positive for herpes simplex virus 1 and showed acyclovir resistance (inhibitor concentration 90 = 200 μg/mL) and foscarnet sensitivity (inhibitor concentration 90 = 200 μg/mL). The patient was treated with topical trifluridine 2-hourly for 3 weeks and weaned off the drops over the following week.
  
  
  RESULTS
  The patient showed resolution of the epithelial defect, but did have significant corneal toxicity associated with the use of the trifluridine. At 8 weeks, the patient had some stromal shadowing associated with the recent active infection, but symptoms had settled.
  
  
  CONCLUSIONS
  This case documents the effective use of topical trifluridine in proven acyclovir-resistant herpetic keratitis. It highlights three things: (1) the importance of considering topical trifluridine as an alternative to topical acyclovir in unresponsive disease; (2) the need to consider solid-organ transplant recipients in the immunocompromised population with resistant herpetic disease, and (3) the need to look for alternatives to treatment of resistant herpetic disease.
authors: Princess Alexandra Hospital, Brisbane, Queensland, Australia.
authors: Liam Daniel
authors: LD
authors: Turner
authors: Peter
authors: P
authors: Beckingsale
keywords: acyclovir resistance; herpetic keratitis; trifluridine
references: Clin Infect Dis. 1997 Nov;25(5):1257-8
references: 9402402
references: Clin Exp Ophthalmol. 2010 Apr;38(3):309-13
references: 20447128
references: J Infect Dis. 2009 Nov 1;200(9):1402-14
references: 19795980
references: Clin Microbiol Rev. 2003 Jan;16(1):114-28
references: 12525428
references: Cornea. 2007 Jan;26(1):105-6
references: 17198024
references: Antimicrob Agents Chemother. 1998 Apr;42(4):868-72
references: 9559798
references: Clin Infect Dis. 2004 Nov 1;39 Suppl 5:S248-57
references: 15494896
references: Acta Ophthalmol (Copenh). 1992 Oct;70(5):690-2
references: 1335203
references: Exp Eye Res. 2000 Oct;71(4):353-9
references: 10995556